Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, along with colleagues Nobuo Ittetsu and Minoru Takada, will be attending the 21st DIA Japan Annual Meeting 2024. This event, held in Tokyo from 27th to 29th October, brings together global leaders in drug development and regulatory science.

The conference will focus on "Driving Patient-Centric Innovation" and offers a unique opportunity for industry professionals to engage in high-level discussions on the latest advancements in drug development, regulatory trends, and innovative technologies in healthcare.

As an attendee, Dr. Taubel will be contributing to the dialogue on cutting-edge clinical research practices. If you would like to connect with us during the event, please feel free to reach out and arrange a meeting.

For more information about the event, please visit the DIA Japan Annual Meeting 2024 website.

Latest news

Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence

September 1, 2025
Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event